Eve & Co Incorporated (TSXV: EVE) this morning announced that it has completed its first commercial shipment of EU-GMP certified cannabis to its German distribution partner, Bavaria Weed GmbH. The shipment is said to be the first “significant” commercial shipment following initial scientific purpose shipment earlier this year.
While the company indicates the shipment is significant, the problem, is that it is entirely unclear what is viewed as being significant. No further details on the shipment were provided, with the company providing no color on the actual size of the exported goods.
Further, the company has previously indicated that the receiver, Bavaria Weed, received its EU GMP certification just this past summer, bringing into question the actual size of its distribution network given its short lifespan. In total, Eve & Co indicates that it has a total of five supply agreements in place with European partners, with product produced at its Natural Medco subsidiary to fulfill these arrangements.
Bulk shipments of product as a result are expected to continue as the necessary import and export permits are issued by Germany and Canada.
Eve & Co Inc last traded at $0.055 on the TSX Venture.
Information for this briefing was found via Sedar and Eve & Co Incorporated. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
